A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms
Clinical trial NCT04435600 · COMPLETED
Trial details
- NCT number
- NCT04435600
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2024-02-12
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.